gday,
wanted to start a discussion on what to expect and how to interpret the upcoming results. Given that we are now in april they can drop at any time.
As i understand it genocea currently have the results we need to compare against as their final phase 2 results are the best out there. Below is a table of their results.
as i don't have a medical background i'm not entirely sure exactly which figures to compare against (hopefully some with appropriate education and background could help here)
Comparing the interim AHZ results against this table, i believe we compare to dose 3 column (as this is what was reported in the interim results) link to announcement here
http://www.asx.com.au/asxpdf/20161019/pdf/43c35546jbmprc.pdf
my humble interpretation:
admedus vs genocea at interim stage
shedding: 58 v 41%
lesions: 81 v 62%
so i believe these next round of results are going to be compared to the last column of genoceas results being the 12 months column.
that is my interpretation, probably wrong but a starting point for us.
those in the know please continue on from here.
very excited for this month and good luck
- Forums
- ASX - By Stock
- AVR
- hsv2 final results
hsv2 final results
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.68 |
Change
-0.320(2.67%) |
Mkt cap ! $246.9M |
Open | High | Low | Value | Volume |
$11.57 | $11.81 | $11.42 | $152.5K | 13.10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 116 | $11.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.68 | 188 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 116 | 11.500 |
1 | 1000 | 11.400 |
1 | 2 | 11.260 |
1 | 8 | 11.220 |
2 | 1045 | 11.200 |
Price($) | Vol. | No. |
---|---|---|
11.680 | 188 | 1 |
11.700 | 1351 | 1 |
11.900 | 1000 | 1 |
12.000 | 4817 | 1 |
12.400 | 198 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online